| Previous Close | 14.05 |
| Open | 14.05 |
| Bid | 12.05 x 100 |
| Ask | 16.95 x 100 |
| Day's Range | 14.05 - 14.25 |
| 52 Week Range | 10.75 - 19.77 |
| Volume | 182,144 |
| Avg. Volume | 215,723 |
| Market Cap | 599.28M |
| Beta | 0.56 |
| PE Ratio (TTM) | 28.40 |
| EPS (TTM) | 0.5 |
| Earnings Date | Nov 8, 2017 - Nov 13, 2017 |
| Dividend & Yield | 0.50 (3.53%) |
| Ex-Dividend Date | 2017-08-03 |
| 1y Target Est | 14.00 |
- GlobeNewswire•5 days ago
Meridian Contributes to Upcoming “LEADCON 2017” – Third Annual International Conference on the Prevention of Lead and Heavy Metal Toxicity in Hyderabad, India
CINCINNATI, Sept. 19, 2017-- Meridian Bioscience, Inc. today announced that Magellan Diagnostics, Inc., a business unit of Meridian, will support and participate in an international conference on the impacts ...
Capital Cube•10 days agoMeridian Bioscience, Inc. breached its 50 day moving average in a Bullish Manner : VIVO-US : September 14, 2017
Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Meridian Bioscience, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bearish ... Read more (Read more...)
- GlobeNewswire•19 days ago
Meridian Launches TRU Block® ULTRA – A Powerful Immunoassay Interference Blocker
CINCINNATI, Sept. 05, 2017-- Meridian Life Science, Inc., of Memphis, Tennessee, a wholly-owned subsidiary of Meridian Bioscience, Inc. today announced the launch of TRU Block ® ULTRA. This product is ...
